BILL ANALYSIS Ó
-----------------------------------------------------------------
|SENATE RULES COMMITTEE | SB 613|
|Office of Senate Floor Analyses | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
-----------------------------------------------------------------
THIRD READING
Bill No: SB 613
Author: Allen (D)
Amended: 4/20/15
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 4/29/15
AYES: Hernandez, Nguyen, Hall, Mitchell, Monning, Nielsen,
Pan, Roth, Wolk
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/28/15
AYES: Lara, Bates, Beall, Hill, Leyva, Mendoza, Nielsen
SUBJECT: State Department of Public Health: dementia
guidelines: workgroup
SOURCE: Alzheimer's Association
DIGEST: This bill requires the Department of Public Health
(DPH) to convene a workgroup to update the 2008 Guidelines for
Alzheimer's Disease Management in California to address changes
in the health care system, and requires DPH to submit a report
of the updates and recommendations from the working group to the
Legislature on or before March 1, 2017.
ANALYSIS:
Existing law:
SB 613
Page 2
1)Requires the California Health and Human Services Agency to
establish an Alzheimer's Disease and Related Disorders
Advisory Committee consisting of 14 members, and requires the
Committee to:
a) Provide ongoing advice and assistance to the
Administration and the Legislature as to the program needs
and priorities of the target population.
b) Provide planning support to the Administration and the
Legislature by updating recommendations of the 1987
California Alzheimer's Disease Task Force Report and
regularly reviewing and updating recommendations as needed.
2)Requires DPH to provide public and professional education on
Alzheimer's disease to educate consumers, caregivers, and
health care providers, and to increase public awareness.
This bill:
1)Requires DPH to convene a workgroup to update the 2008
Guidelines for Alzheimer's Disease Management in California to
address changes in the health care system, including, but not
limited to, changes in the federal Patient Protection and
Affordable Care Act, Medicaid, and Medicare.
2)Permits these updates to further draw on evidence-based,
peer-reviewed research and lessons learned from demonstration
and pilot projects.
3)Requires the workgroup to consist of members determined by
the DPH, and permits the workgroup to include
multidisciplinary experts in Alzheimer's disease detection,
diagnosis, treatment, and support.
4)Requires DPH to submit a report of the updates and
recommendations from the working group to the Legislature on
or before March 1, 2017.
5)Sunsets on January 1, 2018.
Comments:
SB 613
Page 3
1)Author's statement. According to the author, "Alzheimer's
disease is a public health crisis in California, but unlike
other public health concerns there is no known cause, cure or
prevention to reduce the impact on individuals, families,
communities and our state's public programs such as Medi-Cal
and IHSS. The author states we've seen a 42 increase increase
in just the last decade. Experts agree that managing the
course of Alzheimer's disease after a diagnosis is the best
public health strategy we have available today. This bill
proposes a statewide working group under the leadership of
DPH, drawing on the existing resources and expertise of our
state's 10 university-affiliated Alzheimer's Disease Centers.
The author states the state's own experts will update the
physician Guideline for Alzheimer's Disease Management to
systematically improve quality of care, better manage complex
patient populations, and lower public costs associated with
Medi-Cal-funded hospital stays and nursing home placements.
The author concludes that when someone in California learns
they have Alzheimer's, there should be evidence-based, up to
date, guidelines for physicians to follow to ensure the
patients receive the care and support they need."
2)Alzheimer's disease. According to the federal National
Institute on Aging, Alzheimer's disease is an irreversible,
progressive brain disease that slowly destroys memory and
thinking skills, and eventually even the ability to carry out
the simplest tasks. In most people with Alzheimer's, symptoms
first appear after age 65. Plaques and tangles in the brain
are two of the main features of Alzheimer's disease. The third
is the loss of connections between nerve cells (neurons) in
the brain. Although treatment can help manage symptoms in some
people, currently there is no cure for this disease. Estimates
vary, but experts suggest that as many as five million
Americans age 65 and older may have Alzheimer's disease.
Alzheimer's disease is the most common cause of dementia among
older people. Dementia is the loss of cognitive
functioning-thinking, remembering, and reasoning-and
behavioral abilities, to such an extent that it interferes
with a person's daily life and activities. Dementia ranges in
severity from the mildest stage, when it is just beginning to
affect a person's functioning, to the most severe stage, when
the person must depend completely on others for basic
activities of daily living.
SB 613
Page 4
3)2008 Guidelines for Alzheimer's Disease Management. The
"Guideline for Alzheimer's Disease Management - California
Workgroup on Guidelines for Alzheimer's Disease Management
Final Report 2008" was published to update and expand previous
guidelines issued in 2002 and 1998. The 1998 effort was paid
for through a Health Resources and Services Administration
grant. The guidelines were based upon work begun by the Ad Hoc
Standards of Care Committee of the Alzheimer's Disease
Diagnostic and Treatment Centers of California and were
supported in part by the State of California, Department of
Health Services, and the Alzheimer's Association, California.
Southland Chapter. The California Council of the Alzheimer's
Association sponsored the Alzheimer's Disease Education
Initiative (ADEI) and secured a one-time $2.4 million budget
augmentation in FY 2000-01 to launch a public education
campaign centered on the Guidelines for Alzheimer's Disease
Management. The funds from the ADEI were used to pay for the
2002 update.
The 2008 Guidelines state that most older adults, including
those with Alzheimer's disease, receive their medical care
from Primary Care Practitioners (PCPs) who may lack the
information and other resources they need to treat this
growing and demanding population. The 2008 Guidelines was
intended to provide assistance to PCPs in offering
comprehensive care to patients with Alzheimer's disease and
those who care for them over the course of their illness. The
Guidelines' recommendations are organized by major care issues
(assessment, treatment, patient and family education and
support, and legal considerations). Each section of the
guidelines deals with one of the four care issues and provides
an overview of the issue, followed by the care recommendations
and a review of the literature supporting them. The language
used throughout the report reflects the strength of the
supporting evidence, either "strong" (e.g., randomized
clinical trial) or "moderate." In some instances,
recommendations that are not evidence-based are nevertheless
supported by expert opinion and workgroup consensus, and are
labeled as such.
FISCAL EFFECT: Appropriation: No Fiscal
Com.:YesLocal: No
SB 613
Page 5
According to the Senate Appropriations Committee, minor costs to
provide support to the workgroup. The Department of Health Care
Services (DHCS) has already begun the process for reviewing the
available literature and updating the guidelines using an
existing federal grant. The additional responsibilities in this
bill should impose minor costs on DHCS.
SUPPORT: (Verified5/27/15)
Alzheimer's Association (source)
American Federation of State, County and Municipal Employees,
AFL-CIO
California Commission on Aging
Leading Age California
OPPOSITION: (Verified5/27/15)
None received
ARGUMENTS IN SUPPORT: This bill is sponsored by the
Alzheimer's Association to update California's physician
Guideline for Alzheimer's Disease Management to improve quality
of care and support for individuals diagnosed with dementia,
manage complex, costly populations in the state's health care
delivery system, and reduce individual, family and government
health care costs. The Alzheimer's' Association states this bill
draws on the existing resources and expertise within DPH's 10
university-affiliated Alzheimer's Disease Centers to review and
analyze evidence in support of a state-of-the-art guideline for
Alzheimer's disease management. The Alzheimer's Association
states that Medi-Cal beneficiaries with a diagnosis of
Alzheimer's disease have 19 times higher costs than those
without a cognitive impairment. Likewise, patients with dementia
use hospitals and nursing facilities at more than triple the
rate without Alzheimer's. The Alzheimer's Association concludes
that the development of a physician Guideline for Alzheimer's
Disease Management advances public policy for patients,
physicians and government payors.
SB 613
Page 6
Prepared by:Scott Bain / HEALTH /
5/29/15 18:09:29
**** END ****